Spotlight Pathology, a spinout from the University of Manchester, has secured a new investment of £1.4m to accelerate the commercial rollout of its AI cancer diagnostics product. Spotlight Pathology is developing AI-powered tools for diagnosing blood cancer. The firm has picked up a few investments over the past few years, including £425,000 raised in May […] The post Spotlight Pathology secures new funding for AI cancer diagnostics appeared first on UKTN .